Our findings in this study illustrated that the reduction of MYL6B hampered cell proliferation, migration, and invasion, which is consistent with the aforementioned data about the poor outcome in patients with rectal adenocarcinoma. This evidence concerns the gene MYL6B and rectum adenocarcinoma.